US Food and Drug Administration (FDA) Approves First RSV Vaccine for Older Adults

US Food and Drug Administration (FDA) Approves First RSV Vaccine for Older Adults

Daily Current Affairs / US Food and Drug Administration (FDA) Approves First RSV Vaccine for Older Adults

Change Language English Hindi

Category : International Published on: May 06 2023

Share on facebook

The US Food and Drug Administration (FDA) has approved the first vaccine for respiratory syncytial virus (RSV) in the United States.
‘Arexvy’, manufactured by GSK, is the world's first RSVvaccine for adults aged 60 years and older.
The vaccine was approved for people aged 60 and older after it was found 83 percent effective against diseases caused by RSV and more than 94 percent effective against severe diseases.
RSV causes a lower respiratory illness that is typically mild for healthy adults. But in serious cases, the virus can lead to pneumonia or bronchiolitis, which inflames airways and clogs them with mucus.
According to the US Centers for Disease Control and Prevention, it leads to approximately 60,000 to 120,000 hospitalizations and 6,000 to 10,000 deaths among adults 65 years of age and older.

Recent Post's

India halts auction of Lord Buddha’s sacred Piprahwa Relics in Hong Kong, sends legal notice to Sotheby’s.
Read More....
UNSC raises concern over Pakistan's missile tests and LeT links in Pahalgam attack.
Read More....
Russia declares May 8–10 ceasefire for WWII Victory Day; Ukraine rejects it as political stunt.
Read More....
C-DOT and CSIR-NPL sign MoU to boost joint research in classical and quantum communication.
Read More....
Cabinet approves revised SHAKTI policy to grant coal linkages to thermal power plants.
Read More....
INS Kiltan joins IMDEX Asia 2025 in Singapore to strengthen India–Singapore maritime ties.
Read More....
Cabinet approves National Scheme for ITI upgradation and five National Skilling Centres.
Read More....
Indian forces conduct 24 precision strikes on Pakistan-based terror infrastructure.
Read More....
Rohit Sharma announces retirement from Test cricket, continues with ODIs.
Read More....
Moody’s lowers India’s 2025 GDP growth forecast to 6.3% citing global headwinds.
Read More....
India rolls out chip-based e-passports for secure and biometric global travel.
Read More....